|
Market Closed -
Warsaw S.E.
11:55:45 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 7.800 PLN | -0.64% |
|
-0.51% | +11.75% |
| 08-26 | Oddifact and Mabion Receive Fda Type B Pre-Ind Meeting Grant for Rtx-Np in Immune Thrombocytopenia | CI |
| 05-19 | Mabion Q1 net loss 9.7 million zlotys | RE |
| Market Cap | 126M 33.71M 29.05M 27.23M 24.86M 46.83M 3.22B 46.98M 323M 1.63B 127M 124M 5.39B | P/E 2024 |
-22.7x | P/E 2025 | -1.8x |
|---|---|---|---|---|---|
| Enterprise Value | 132M 35.4M 30.5M 28.6M 26.11M 49.18M 3.38B 49.34M 339M 1.71B 133M 130M 5.66B | EV / Sales 2024 |
1,574,345x | EV / Sales 2025 | 7,560,388x |
| Free-Float |
67.18% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.64% | ||
| 1 week | -0.51% | ||
| Current month | +4.56% | ||
| 1 month | +5.12% | ||
| 3 months | +4.56% | ||
| 6 months | -4.29% | ||
| Current year | +11.75% |
| 1 week | 7.71 | 8.47 | |
| 1 month | 7.35 | 8.47 | |
| Current year | 7.01 | 10 | |
| 1 year | 6.7 | 10 | |
| 3 years | 6.7 | 23.6 | |
| 5 years | 6.7 | 110 | |
| 10 years | 6.7 | 139 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregor Kawaletz
CEO | Chief Executive Officer | - | - |
| Corporate Officer/Principal | - | - | |
| Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wojciech Wosko
BRD | Director/Board Member | - | 2021-02-22 |
| Chairman | 60 | 2021-05-12 | |
| Director/Board Member | 53 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.64% | -0.51% | -16.13% | -52.44% | 33.71M | ||
| -1.59% | -3.35% | +52.37% | +91.62% | 69.54B | ||
| -1.34% | -0.75% | +48.21% | +92.23% | 64.97B | ||
| +0.30% | -0.69% | +52.56% | +9.51% | 26.51B | ||
| -2.35% | -5.75% | -12.90% | +436.87% | 25.89B | ||
| -8.37% | -12.43% | +2.08% | -18.39% | 25.64B | ||
| -0.96% | +10.36% | +283.06% | +429.04% | 20.22B | ||
| -0.51% | +0.23% | +35.77% | -19.61% | 19.98B | ||
| -1.91% | -4.37% | +13.28% | +557.93% | 15.69B | ||
| -1.47% | +0.68% | +45.51% | +142.00% | 13.49B | ||
| Average | -1.88% | -1.78% | +50.38% | +166.88% | 28.2B | |
| Weighted average by Cap. | -1.93% | -1.50% | +53.72% | +150.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 69.02 18.45 15.9 14.91 13.61 25.64 1.76K 25.72 176.9 890.35 69.29 67.78 2.95K | 15.76 4.21 3.63 3.4 3.11 5.85 402.67 5.87 40.39 203.27 15.82 15.47 674 |
| Net income | -6.33M -1.69M -1.46M -1.37M -1.25M -2.35M -162M -2.36M -16.23M -81.71M -6.36M -6.22M -271M | -62.61M -16.74M -14.43M -13.53M -12.35M -23.26M -1.6B -23.34M -160M -808M -62.86M -61.49M -2.68B |
| Net Debt | -35.18M -9.41M -8.11M -7.6M -6.94M -13.07M -899M -13.11M -90.18M -454M -35.32M -34.55M -1.51B | 6.32M 1.69M 1.46M 1.36M 1.25M 2.35M 161M 2.35M 16.19M 81.48M 6.34M 6.2M 270M |
Employees
202
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | PLN 7.800 | -0.64% | 19,266 |
| 26-08-27 | PLN 7.850 | -0.38% | 56,855 |
| 26-08-26 | PLN 7.880 | +2.07% | 247,262 |
| 26-08-25 | PLN 7.720 | -1.53% | 17,097 |
| 26-08-24 | PLN 7.840 | 0.00% | 18,872 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MAB Stock
Select your edition
All financial news and data tailored to specific country editions
















